logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

WCLC 2019 – Immune-related adverse events are associated with improved clinical outcomes to immunotherapy in patients with SCLC

Immune-related adverse events occur early in patients with SCLC treated with immune checkpoint inhibitors and seem to correlate with biomarkers of treatment efficacy